Dietary glycine inhibits angiogenesis during wound healing and tumor growth

Cancer Biology and Therapy

Volumn 2, Issue 2, 2003, Pages 173-178

  Amin, Khalid ^a   Li, Jie ^b   Chao, Wan Ru ^a   Dewhirst, Mark W ^b   Haroon, Zishan A ^a  

^a SRI INTERNATIONAL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Fibrin; Glycine; iNOS; Wound healing; Z chambers

Indexed keywords

ANGIOGENESIS INHIBITOR; FIBRIN; GLYCINE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT;

ANIMAL; ARTICLE; CELL DIVISION; CHEMISTRY; CHORION; DIET; DRUG EFFECT; ENZYME IMMUNOASSAY; ENZYMOLOGY; EXPERIMENTAL NEOPLASM; FEMALE; FETUS MEMBRANE; FISCHER 344 RAT; GEL; GRANULATION TISSUE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; RAT; WESTERN BLOTTING; WOUND HEALING;

ALLANTOIS; ANGIOGENESIS INHIBITORS; ANIMALS; BLOTTING, WESTERN; CELL DIVISION; CHORION; DIET; FEMALE; FIBRIN; GELS; GLYCINE; GRANULATION TISSUE; IMMUNOENZYME TECHNIQUES; MAMMARY NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, INBRED F344; WOUND HEALING;

EID: 0141872587     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.2.2.280     Document Type: Article

References (42)

1. Rajendra S, Lynch JW, Schofield PR. The glycine receptor. Pharmacol Ther 1997; 73:121-46. (Pubitemid 27191614)
2. Wheeler MD, Ikejema K, Enomoto N, Stacklewitz RF, Seabra V, Zhong Z, et al. Glycine: a new anti-inflammatory immunonutrient. Cell Mol Life Sci 1999; 56:843-56.
3. Ikejima K, Qu W, Stachlewitz RF, Thurman RG. Kupffer cells contain a glycine-gated chloride channel. Am J Physiol 1997; 272:G1581-6.
4. Wheeler MD, Rose ML, Yamashima S, Enomoto N, Seabra V, Madren J, Thurman RG. Dietary glycine blunts lung inflammatory cell influx following acute endotoxin. Am J Physiol Lung Cell Mol Physiol 2000; 279:L390-8.
5. Li X, Bradford BU, Wheeler MD, Stimpson SA, Pink HM, Brodie TA, et al. Dietary glycine prevents peptidoglycan polysaccharide-induced reactive arthritis in the rat: role for glycine-gated chloride channel. Infect Immun 2001; 69:5883-91. (Pubitemid 32786529)
6. Yin M, Ikejima K, Arteel GE, Seabra V, Bradford BU, Kono H, et al. Glycine accelerates recovery from alcohol-induced liver injury. J Pharmacol Exp Ther 1998; 286:1014-9. (Pubitemid 29003498)
7. Rivera CA, Bradford BU, Hunt KJ, Adachi Y, Schrum LW, Koop DR, et al. Attenuation of CCl(4)-induced hepatic fibrosis by GdCl(3) treatment or dietary glycine. Am J Physiol Gastrointest Liver Physiol 2001; 281:G200-7.
8. Thurman RG, Schemmer P, Zhong Z, Bunzendahl H, von Frankenberg M, Lemasters JJ. Kupffer cell-dependent reperfusion injury in liver transplantation: new clinically relevant use of glycine. Langenbecks Arch Chir Suppl Kongressbd 1998; 115:185-90.
9. Thurman RG, Zhong Z, von Frankenberg M, Stachlewitz RF, Bunzendahl H. Prevention of cyclosporine-induced nephrotoxicity with dietary glycine. Transplantation 1997; 63:1661-7. (Pubitemid 27265511)
10. Risau W. Mechanisms of angiogenesis. Nature 1997; 386:671-4. (Pubitemid 27193480)
11. Norrby K. Angiogenesis: new aspects relating to its initiation and control. Apmis 1997; 105: 417-37. (Pubitemid 27314455)
12. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1:27-31.
13. Rickles FR. Relationship of blood clotting and tumor angiogenesis. Haemostasis 2001; 31:16-20.
14. Nash GF, Walsh DC, Kakkar AK. The role of the coagulation system in tumor angiogenesis. Lancet Oncol 2001; 2:608-13. (Pubitemid 33009256)
15. Rose ML, Madren J, Bunzendahl H, Thurman RG. Dietary glycine inhibits the growth of B16 melanoma tumors in mice. Carcinogenesis 1999; 20:793-8. (Pubitemid 29191860)
16. Rose ML, Cattley RC, Dunn C, Wong V, Li X, Thurman RG. Dietary glycine prevents the development of liver tumors caused by the peroxisome proliferator WY-14,643. Carcinogenesis 1999; 20:2075-81.
17. Tanaka NG, Sakamoto N, Tohgo A, Nishiyama Y, Ogawa H. Inhibitory effects of anti-angiogenic agents on neovascularization and growth of the chorioallantoic membrane (CAM). The possibility of a new CAM assay for angiogenesis inhibition. Exp Pathol 1986; 30:143-50.
18. Dvorak HF, Harvey VS, Estrella P, Brown LF, McDonagh J, Dvorak AM. Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest 1987; 57:673-86.
19. Haroon ZA, Amin K, Saito W, Wilson W, Greenberg CS, Dewhirst MW. SU5416 delays wound healing through inhibition of TGF-beta 1 activation. Cancer Biol Ther 2002; 1: 121-6.
20. Rohr S, Toti F, Brisson C, Albert A, Freund M, Meyer C, Cazenave JP. Quantitative image analysis of angiogenesis in rats implanted with a fibrin gel chamber. Nouv Rev Fr Hematol 1992; 34:287-94.
21. Arcasoy MO, Amin K, Karayal AF, Chou SC, Raleigh JA, Varia MA, Haroon ZA. Functional significance of erythropoietin receptor expression in breast cancer. Lab Invest 2002; 82:911-8. (Pubitemid 34761666)
22. Haroon ZA, Hettasch JM, Lai TS, Dewhirst MW, Greenberg CS. Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis. Faseb J 1999; 13:1787-95. (Pubitemid 29473340)
23. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992; 84:1875-87. (Pubitemid 23004615)
24. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15:323-50. (Pubitemid 27169284)
25. Woodson K, Triantos S, Hartman T, Taylor PR, Virtamo J, Albanes D. Long-term alpha-tocopherol supplementation is associated with lower serum vascular endothelial growth factor levels. Anticancer Res 2002; 22:375-8. (Pubitemid 34475325)
26. Hardman WE, Munoz J, Jr., Cameron IL. Role of lipid peroxidation and antioxidant enzymes in omega 3 fatty acids induced suppression of breast cancer xenograft growth in mice. Cancer Cell Int 2002; 2:10.
27. Colic M, Pavelic K. Molecular mechanisms of anticancer activity of natural dietetic products. J Mol Med 2000; 78:333-6
28. Melkonian G, Munoz N, Chung J, Tong C, Marr R, Talbot P. Capillary plexus development in the day five to day six chick chorioallantoic membrane is inhibited by cytochalasin D and suramin. J Exp Zool 2002; 292:241-54. (Pubitemid 34166136)
29. Auerbach R, Auerbach W, Polakowski I. Assays for angiogenesis: a review. Pharmacol Ther 1991; 51:1-11.
30. Jadeski LC, Lala PK. Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors. Am J Pathol 1999; 155: 1381-90. (Pubitemid 29488945)
31. Schaffer MR, Tantry U, Gross SS, Wasserburg HL, Barbul A. Nitric oxide regulates wound healing. J Surg Res 1996; 63:237-40. (Pubitemid 26197729)
32. Witte MB, Barbul A. Role of nitric oxide in wound repair. Am J Surg 2002; 183:406-12. (Pubitemid 34442505)
33. Shi HP, Efron DT, Most D, Tantry US, Barbul A. Supplemental dietary arginine enhances wound healing in normal but not inducible nitric oxide synthase knockout mice. Surgery 2000; 128:374-8. (Pubitemid 30622508)
34. Thornton FJ, Schaffer MR, Witte MB, Moldawer LL, MacKay SL, Abouhamze A, et al. Enhanced collagen accumulation following direct transfection of the inducible nitric oxide synthase gene in cutaneous wounds. Biochem Biophys Res Commun 1998; 246:654-9. (Pubitemid 28420914)
35. Reichner JS, Meszaros AJ, Louis CA, Henry WL, Jr., Mastrofrancesco B, Martin BA, et al. Molecular and metabolic evidence for the restricted expression of inducible nitric oxide synthase in healing wounds. Am J Pathol 1999; 154:1097-104. (Pubitemid 29169744)
36. Lingen MW. Role of leukocytes and endothelial cells in the development of angiogenesis in inflammation and wound healing. Arch Pathol Lab Med 2001; 125:67-71. (Pubitemid 32096187)
37. Wheeler MD, Thurman RG. Production of superoxide and TNF-alpha from alveolar macrophages is blunted by glycine. Am J Physiol 1999; 277:L952-9.
38. Xie K, Fidler IJ. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Metastasis Rev 1998; 17:55-75. (Pubitemid 28194646)
39. Thomsen LL, Miles DW. Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Rev 1998; 17:107-18. (Pubitemid 28194649)
40. Vakkala M, Kahlos K, Lakari E, Paakko P, Kinnula V, Soini Y. Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas. Clin Cancer Res 2000; 6:2408-16. (Pubitemid 30399209)
41. Jang TJ, Kim DK. Inducible nitric oxide synthase expression of tumor and stromal cells is associated with the progression of 7,12-dimethylbenz[a] anthracene- induced rat mammary tumors. Cancer Lett 2002; 182:121-6. (Pubitemid 34621174)
42. Haroon ZA, Lai TS, Hettasch JM, Lindberg RA, Dewhirst MW, Greenberg CS. Tissue transglutaminase is expressed as a host response to tumor invasion and inhibits tumor growth. Lab Invest 1999; 79:1679-86. (Pubitemid 30013931)